Patents by Inventor Joseph David

Joseph David has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ATOVAQUONE AND PROGUANIL FOR TREATMENT OF GASTROINTESTINAL DISEASES AND INFLAMMATION
    Publication number: 20250177323
    Abstract: The disclosure relates to the use of atovaquone or a salt thereof, and, optionally, proguanil or a salt thereof, for the treatment of various human diseases and conditions, including gastrointestinal disorders and, in particular, those associated with inflammation, such as inflammatory bowel disease (IBD), ulcerative colitis (UC), and Crohn's disease (CD).
    Type: Application
    Filed: February 10, 2025
    Publication date: June 5, 2025
    Applicant: Elevaid Therapeutics, Inc.
    Inventor: Joseph David
  • Use of atovaquone and proguanil for treatment of gastrointestinal diseases and inflammation
    Patent number: 12245994
    Abstract: The disclosure relates to the use of atovaquone or a salt thereof, and, optionally, proguanil or a salt thereof, for the treatment of various human diseases and conditions, including gastrointestinal disorders and, in particular, those associated with inflammation, such as inflammatory bowel disease (IBD), ulcerative colitis (UC), and Crohn's disease (CD).
    Type: Grant
    Filed: December 2, 2022
    Date of Patent: March 11, 2025
    Assignee: Elevaid Therapeutics, Inc.
    Inventor: Joseph David
  • Use of atovaquone and proguanil for treatment of gastrointestinal diseases and inflammation
    Patent number: 12102605
    Abstract: The disclosure relates to the use of atovaquone or a salt thereof, and, optionally, proguanil or a salt thereof, for the treatment of various human diseases and conditions, including gastrointestinal disorders and, in particular, those associated with inflammation, such as inflammatory bowel disease (IBD), ulcerative colitis (UC), and Crohn's disease (CD).
    Type: Grant
    Filed: January 24, 2024
    Date of Patent: October 1, 2024
    Assignee: Elevaid Therapeutics, Inc.
    Inventor: Joseph David
  • USE OF ATOVAQUONE AND PROGUANIL FOR REDUCING STEROID USE, ALL-CAUSE HOSPITALIZATION, OR ADVANCED THERAPY USE IN A SUBJECT DIAGNOSED WITH INFLAMMATORY BOWEL DISEASE, CROHN'S DISEASE, OR ULCERATIVE COLITIS
    Publication number: 20240245629
    Abstract: This disclosure provides a method of reducing steroid use, all-cause hospitalization, and/or advanced therapy use in a subject diagnosed inflammatory bowel disease, Crohn's disease, or ulcerative colitis. In some embodiments, the method comprises administering to the subject a therapeutically effective amount of atovaquone or a salt thereof in combination with proguanil or a salt thereof.
    Type: Application
    Filed: February 16, 2024
    Publication date: July 25, 2024
    Applicant: Elevaid Therapeutics, Inc.
    Inventor: Joseph David
  • USE OF ATOVAQUONE AND PROGUANIL FOR TREATMENT OF GASTROINTESTINAL DISEASES AND INFLAMMATION
    Publication number: 20240165051
    Abstract: The disclosure relates to the use of atovaquone or a salt thereof, and, optionally, proguanil or a salt thereof, for the treatment of various human diseases and conditions, including gastrointestinal disorders and, in particular, those associated with inflammation, such as inflammatory bowel disease (IBD), ulcerative colitis (UC), and Crohn's disease (CD).
    Type: Application
    Filed: January 24, 2024
    Publication date: May 23, 2024
    Applicant: Elevaid Therapeutics, Inc.
    Inventor: Joseph David
  • USE OF ATOVAQUONE AND PROGUANIL FOR TREATMENT OF GASTROINTESTINAL DISEASES AND INFLAMMATION
    Publication number: 20230201135
    Abstract: The disclosure relates to the use of atovaquone or a salt thereof, and, optionally, proguanil or a salt thereof, for the treatment of various human diseases and conditions, including gastrointestinal disorders and, in particular, those associated with inflammation, such as inflammatory bowel disease (IBD), ulcerative colitis (UC), and Crohn's disease (CD).
    Type: Application
    Filed: December 2, 2022
    Publication date: June 29, 2023
    Applicant: Elevaid Therapeutics, Inc.
    Inventor: Joseph David
  • Electronic networking and notification system
    Publication number: 20070174397
    Abstract: An electronic system and method for networking and notification that permits a law enforcement officer from a first agency to obtain database information relating to a law enforcement seizure from databases belonging to other agencies. Such access is facilitated by a web-site maintained at a notification server, which acts as a hub between, on the one hand, notifying devices that may be operated by law enforcement agents in the fields, and agency devices, that may be operated by agencies having access to searchable databases.
    Type: Application
    Filed: January 25, 2006
    Publication date: July 26, 2007
    Inventor: Joseph David